USD 74.95
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 1.33 Billion USD | 45.93% |
2023 | 913.06 Million USD | -3.84% |
2022 | 949.48 Million USD | -19.07% |
2021 | 1.17 Billion USD | 11.89% |
2020 | 1.04 Billion USD | 8.9% |
2019 | 962.77 Million USD | -0.61% |
2018 | 968.65 Million USD | -20.56% |
2017 | 1.21 Billion USD | 5.46% |
2016 | 1.15 Billion USD | 25.67% |
2015 | 919.98 Million USD | -19.69% |
2014 | 1.14 Billion USD | 35.52% |
2013 | 845.33 Million USD | 30.11% |
2012 | 649.72 Million USD | 5.51% |
2011 | 615.76 Million USD | 35.82% |
2010 | 453.38 Million USD | 4.42% |
2009 | 434.21 Million USD | -22.57% |
2008 | 560.76 Million USD | 22.56% |
2007 | 457.53 Million USD | 27.68% |
2006 | 358.35 Million USD | 4.06% |
2005 | 344.37 Million USD | 1.8% |
2004 | 338.28 Million USD | 0.7% |
2003 | 335.92 Million USD | 10.48% |
2002 | 304.05 Million USD | -51.9% |
2001 | 632.17 Million USD | -50.8% |
2000 | 1.28 Billion USD | -19.25% |
1999 | 1.59 Billion USD | 13.76% |
1998 | 1.39 Billion USD | -33.92% |
1997 | 2.11 Billion USD | -17.96% |
1996 | 2.58 Billion USD | 8.44% |
1995 | 2.37 Billion USD | 2.21% |
1994 | 2.32 Billion USD | 22.02% |
1993 | 1.9 Billion USD | -12.83% |
1992 | 2.18 Billion USD | 14.17% |
1991 | 1.91 Billion USD | 2.97% |
1990 | 1.86 Billion USD | 8.21% |
1989 | 1.72 Billion USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 1.33 Billion USD | 41.58% |
2024 FY | 1.33 Billion USD | 45.93% |
2024 Q4 | 1.33 Billion USD | 0.0% |
2024 Q1 | 941.1 Million USD | 3.07% |
2024 Q2 | 941.1 Million USD | 0.0% |
2023 FY | 913.06 Million USD | -3.84% |
2023 Q2 | 980.2 Million USD | 0.0% |
2023 Q4 | 913.06 Million USD | -0.23% |
2023 Q3 | 915.2 Million USD | -6.63% |
2023 Q1 | 980.2 Million USD | 3.23% |
2022 Q2 | 1.03 Billion USD | 0.0% |
2022 FY | 949.48 Million USD | -19.07% |
2022 Q4 | 949.48 Million USD | 0.0% |
2021 Q2 | 1.1 Billion USD | 0.0% |
2021 FY | 1.17 Billion USD | 11.89% |
2021 Q4 | 1.17 Billion USD | 0.0% |
2020 Q2 | 1.05 Billion USD | 0.0% |
2020 FY | 1.04 Billion USD | 8.9% |
2020 Q4 | 1.05 Billion USD | 0.0% |
2019 FY | 962.77 Million USD | -0.61% |
2019 Q4 | 962.77 Million USD | 0.0% |
2019 Q2 | 1.38 Billion USD | 0.0% |
2018 Q2 | 1.27 Billion USD | 0.0% |
2018 FY | 968.65 Million USD | -20.56% |
2018 Q4 | 715.69 Million USD | 0.0% |
2017 FY | 1.21 Billion USD | 5.46% |
2017 Q2 | 1.54 Billion USD | 0.0% |
2017 Q4 | 935.26 Million USD | 0.0% |
2016 FY | 1.15 Billion USD | 25.67% |
2016 Q2 | 1.61 Billion USD | 0.0% |
2016 Q4 | 860.89 Million USD | 0.0% |
2015 Q4 | 919.98 Million USD | 0.0% |
2015 FY | 919.98 Million USD | -19.69% |
2015 Q2 | 1.38 Billion USD | 0.0% |
2014 Q3 | 1.21 Billion USD | -9.51% |
2014 Q2 | 1.34 Billion USD | 11.12% |
2014 FY | 1.14 Billion USD | 35.52% |
2014 Q4 | 1.14 Billion USD | -5.85% |
2014 Q1 | 1.21 Billion USD | 43.16% |
2013 Q4 | 845.33 Million USD | -9.36% |
2013 Q3 | 932.6 Million USD | 7.84% |
2013 Q2 | 864.77 Million USD | -0.81% |
2013 Q1 | 871.87 Million USD | 34.19% |
2013 FY | 845.33 Million USD | 30.11% |
2012 Q4 | 649.72 Million USD | 0.0% |
2012 FY | 649.72 Million USD | 5.51% |
2011 FY | 615.76 Million USD | 35.82% |
2011 Q4 | 615.76 Million USD | 0.0% |
2010 Q4 | 453.38 Million USD | 0.0% |
2010 FY | 453.38 Million USD | 4.42% |
2009 Q4 | 434.21 Million USD | 0.0% |
2009 FY | 434.21 Million USD | -22.57% |
2008 FY | 560.76 Million USD | 22.56% |
2008 Q4 | 560.76 Million USD | 0.0% |
2007 FY | 457.53 Million USD | 27.68% |
2007 Q4 | 457.53 Million USD | 0.0% |
2006 FY | 358.35 Million USD | 4.06% |
2006 Q4 | 482.92 Million USD | 0.0% |
2005 Q4 | 344.37 Million USD | 0.0% |
2005 FY | 344.37 Million USD | 1.8% |
2004 Q4 | 338.28 Million USD | 0.0% |
2004 FY | 338.28 Million USD | 0.7% |
2003 Q4 | 335.92 Million USD | 0.0% |
2003 FY | 335.92 Million USD | 10.48% |
2002 Q4 | 304.05 Million USD | 0.0% |
2002 FY | 304.05 Million USD | -51.9% |
2001 Q4 | 632.17 Million USD | 0.0% |
2001 FY | 632.17 Million USD | -50.8% |
2000 FY | 1.28 Billion USD | -19.25% |
2000 Q4 | 1.28 Billion USD | 0.0% |
1999 Q4 | 1.59 Billion USD | 0.0% |
1999 FY | 1.59 Billion USD | 13.76% |
1998 Q4 | 1.39 Billion USD | 0.0% |
1998 FY | 1.39 Billion USD | -33.92% |
1997 Q4 | 2.11 Billion USD | 0.0% |
1997 FY | 2.11 Billion USD | -17.96% |
1996 FY | 2.58 Billion USD | 8.44% |
1995 FY | 2.37 Billion USD | 2.21% |
1994 FY | 2.32 Billion USD | 22.02% |
1993 FY | 1.9 Billion USD | -12.83% |
1992 FY | 2.18 Billion USD | 14.17% |
1991 FY | 1.91 Billion USD | 2.97% |
1990 FY | 1.86 Billion USD | 8.21% |
1989 FY | 1.72 Billion USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
American Medical Technologies Inc. | 2.34 Million USD | -56601.636% |
Ansell Limited | 1.32 Billion USD | -0.188% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 126.33 Million USD | -954.633% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 943.17 Thousand USD | -141167.977% |
Psykey, Inc. | 2.47 Million USD | -53755.69% |
ConvaTec Group Plc | 2.01 Billion USD | 33.979% |
ConvaTec Group Plc | 2.02 Billion USD | 34.072% |
Encision Inc. | 1.98 Million USD | -67058.341% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 3.04 Million USD | -43722.043% |
Innovative MedTech Inc. | 6.13 Million USD | -21618.567% |
LifePoint, Inc. | 2.45 Million USD | -54191.29% |
Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -12987.123% |
Paradigm Medical Industries, Inc. | 3.4 Million USD | -39088.235% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 3.04 Million USD | -43724.291% |
Reflect Scientific, Inc. | 776.32 Thousand USD | -171528.266% |
SmileDirectClub, Inc. | 982.26 Million USD | -35.646% |
Sector 10, Inc. | 9.84 Million USD | -13433.185% |
Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 1.719% |
SheerVision, Inc. | 1.43 Million USD | -92983.499% |
United Health Products, Inc. | 1.99 Million USD | -66557.695% |
Vasamed, Inc. | 1 Million USD | -132437.551% |
Wearable Health Solutions, Inc. | 3.8 Million USD | -34960.528% |
Yubo International Biotech Limited | 2.91 Million USD | -45625.283% |